HBRM News Alert Herborium Group Inc. (HBRM) 0.0004 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Herborium Group Inc. (HBRM) 0.0004 $HBRM

HERBORIUM Issues Letter to Shareholders To Address Reverse Stock Rumors
GlobeNewswire - Wed Feb 11, 9:56AM CST
Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company's (a provider of unique, all botanical medicines) CEO and Chairwomen Dr. Agnes P. Olszewski issued the following Letter to Shareholders today to respond to rumors of a pending reverse stock split of Herborium's stock.

Herborium's Botanical Therapeutics(r) AcnEase(r) and Women and Men Sexual Formulas featured by "Ask The Doctor with Dr. Christian Jessen" UK most popular health focused publication.
GlobeNewswire - Tue Feb 03, 11:17AM CST
Herborium(R) Group, Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and provider of unique, all botanical medicines (Botanical Therapeutics(R)), announced today that its unique all herbal acne treatment, AcnEase(R), will be featured in an editorial in the UK's most popular health focused publication, AT HOME MAGAZINE's Ask the Doctor with Dr. Christian Jessen on February 4th, 2015.

Herborium Group 2014 Sales Grows 75% Over 2013
GlobeNewswire - Thu Jan 29, 10:16AM CST
Fort Lee, N.J. Januray 29, 2015 Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicines (Botanical Therapeutics(R)) announced today that its 2014 sales of AcnEase(R) proprietary acne treatment grew over 75% in comparison to 2013.

Herborium's CEO Interviewed on Clear Channel - iHeart Business Talk Radio's "The Trader's Network" on January 17th, 2015
GlobeNewswire - Wed Jan 21, 9:55AM CST
Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company providing unique, all botanical medicines (Botanical Therapeutics(R)), announced today that the Company's CEO, Dr. Agnes P. Olszewski has been interviewed live by Michael Yorba, the host, on Clear Channel - iHeart Business Talk Radio's "The Trader's Network" Show on January 17, 2015 at 1:00pm ET |10:00am PT | 12:00pm CT (U.S.)

Herborium's CEO Will Be Interviewed on Clear Channel - iHeart Business Talk Radio's "The Trader's Network" on January 17th, 2015
GlobeNewswire - Fri Jan 16, 7:30AM CST
Herborium(R) Group, Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company providing unique, all botanical medicines (Botanical Therapeutics(R)), announced today that the Company's CEO, Dr. Agnes P. Olszewski will be interviewed live by Michael Yorba, the host, on Clear Channel - iHeart Business Talk Radio's "The Trader's Network" Show on January 17, 2015.

Herborium Increases its Sales on Amazon 54% Over 2013
GlobeNewswire - Thu Jan 08, 11:19AM CST
Herborium(R) Group, Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company providing unique, all botanical medicines (Botanical Therapeutics(R)), announced today that its Amazon sales grew 54% over sales for the same period in 2013. This very significant increase in revenue results from a 25% increase in the number of orders and a 37% increase in the average value of the order. The increase in the average value of the order is especially significant since it indicates a growing consumer confidence in Herborium and its products.

Herborium Expands Its HUT Group Partnership to Reach [Pounds]500,000 ($785,000.00) Sales in Europe.
GlobeNewswire - Thu Dec 11, 8:00AM CST
Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicines (Botanical Therapeutics(R)) announced today that HUT Group, LLC. , the UK's leading multi-website online retailer of Health and Beauty products is expending the marketing and sales of AcnEase(R), Herborium's unique acne treatment on its leading platforms with a goal of £500,000.00 ($785,000.00) in sales within next 18-24 months. Hut will also introduce Herborium' women, men and energy products in the European market in 2015.

Herborium Exceeds Target Sales for Black Friday and Cyber Monday by 80% Over 2013
GlobeNewswire - Thu Dec 04, 9:03AM CST
Herborium(R) Group, Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company providing unique, all botanical medicines (Botanical Therapeutics(R)), announced today that its Black Friday and Cyber Monday sales results grew 80% over the same sales events in 2013.

Herborium Group Establishing a Strong foothold in $7 Billion Rapidly Growing French Beauty Market
GlobeNewswire - Thu Oct 30, 7:32AM CDT
Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique, all botanical medicines (Botanical Therapeutics(R)) announced today that AcnEase(R) their proprietary all botanical acne treatment has established a strong foothold in the $7 Billion beauty market in France with a 200% increase in country sales since January 2014.

Herborium Group 2014 Third Quarter Sales Grows 105% Over the Same Quarter in 2013
GlobeNewswire - Thu Oct 16, 9:33AM CDT
Herborium(R) Group, Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicines (Botanical Therapeutics(R)) announced today that its Third Quarter sales for 2014 grew 105% over the same quarter in 2013

Herborium Group Presented at the Prestigious 7th Annual "Life Science Stakeholders Summit" in Philadelphia
GlobeNewswire - Mon Oct 06, 11:01AM CDT
Herborium(R) Group, Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicines (Botanical Therapeutics(R)) has presented the Company's opportunities and its unique all botanical treatments at the 7 Annual "Life Science Stakeholders Summit" on Thursday, October 2 2014. The Conference was focused on latest innovations and disruptive technologies and their impact on healthcare, and was sponsored by Livingston Securities LLC., and BakerHostetler LLP.

Herborium Group's Unique Acne Treatment Featured by the largest PR Beauty Network
GlobeNewswire - Thu Sep 25, 10:55AM CDT
Herborium Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics Company and the provider of unique, all botanical, medicinal products (Botanical Therapeutics) announced today that it's unique, all botanical, treatment for acne AcnEase, has been featured at the BeautyPress Spotlight Event, on September 24 in New York City, as one of only 10 innovative products selected for exhibition at this event.

Herborium Group starts the commercialization of its sexual health formulas; ready to take advantage of $1.5 billion market.
GlobeNewswire - Thu Sep 11, 9:17AM CDT
Herborium Group, Inc., (HBRM) www.herborium.com, a Botanical Therapeutics(R) Company has announced today that it has signed an agreement with a Florida company to commercialize its proprietary, all botanical based sexual Botanical Therapeutics(R): The Lasting Pleasure(R) for Women and Lasting Power(R) for Men. The products are going to be on the market in 4 quarter of 2014.

Herborium Group enters $300 billion plus mobile sales market;
GlobeNewswire - Thu Aug 21, 8:30AM CDT
Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicinal products (Botanical Therapeutics(R)) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress, has successfully deployed a responsive design e-commerce infrastructure and joined $300 billion plus mobile market.

Herborium Group's 2014 First Seven Months Sales Surpasses 2013 Annual Sales.
GlobeNewswire - Thu Jul 24, 7:41AM CDT
Fort Lee, N.J. July 24, 2014 Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicinal products (Botanical Therapeutics(R)) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress, reports that its sales for the first seven months of 2014 has surpassed the sales realized in the entire year of 2013. This reaffirms the present run rate for AcnEase(R) sales for 2014 to exceed $1 million dollars.

Herborium Group's Second Quarter Sales Grows over 132%
GlobeNewswire - Thu Jul 17, 7:30AM CDT
Fort Lee, N.J. July 16, 2014 Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicinal products (Botanical Therapeutics(R)) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress, reports that its sales for the Second Quarter of 2014 grew by 132 % in comparison to the same period of 2013. This puts the present run rate for AcnEase(R) sales for 2014 to exceed $1 million dollars. .




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 4

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 5

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Celebree Gains Franchise Momentum: A New Frontier

Updated Category News Views 4

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 5

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 6

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 4

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 4

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 3

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 2

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 5

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors in Novo Nordisk A/S Must Act Quickly to Protect Rights

Updated Category News Views 104

Important Legal Notice for Novo Nordisk A/S Investors Investors of Novo Nordisk A/S have become the focus of a significant legal matter. Levi & Korsinsky, LLP has announced that shareholders should take immediate action regarding their rights due to an ongoing class action securities lawsuit. This situation arises from claims of alleged securities fraud affecting...

Continue Reading
Immunovia Advances Pancreatic Cancer Testing at PRECEDE Meeting

Updated Category News Views 90

Immunovia Advances Pancreatic Cancer Testing at PRECEDE Meeting Immunovia, a pioneering diagnostics company focused on pancreatic cancer, recently presented significant findings at the annual gathering of the PRECEDE Consortium. This esteemed consortium consists of 51 leading pancreatic cancer centers worldwide, dedicated to advancing early detection methods. The...

Continue Reading
Modine Manufacturing: Earnings Insights & Market Overview

Updated Category News Views 221

Modine Manufacturing Earnings Preview Modine Manufacturing (NYSE: MOD) is gearing up to announce its earnings report soon, and there are several key aspects investors should consider prior to this release. The market is abuzz with anticipation as analysts project an earnings per share (EPS) of $0.92. Investors are hopeful that the company will surpass these estimates and...

Continue Reading
DBV Technologies' Insights on Food Allergy Management Strategies

Updated Category News Views 216

DBV Technologies' Participation at ACAAI Annual Meeting DBV Technologies (NASDAQ: DBVT) is set to take part in a significant scientific event, the American College of Allergy, Asthma & Immunology (ACAAI) 2025 Annual Scientific Meeting. Scheduled for November 6-10, this prestigious meeting will occur in a vibrant location, drawing experts from various fields of allergy and...

Continue Reading
Strengthening Sanctions Against Ivanishvili: A Call to Action

Updated Category News Views 214

Strengthening Sanctions Against Ivanishvili: A Call to Action Robert Amsterdam, the founding partner of Amsterdam & Partners LLP, emphasizes the urgent need for action against Bidzina Ivanishvili, calling for increased sanctions in light of ongoing legal proceedings involving his client, George Bachiashvili. The Context of the Case The trial against Bachiashvili centers...

Continue Reading